← Product Code [JXL](/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/JXL) · K050188 # EPIGUARD (K050188) _Episafe Medical Devices, Ltd. · JXL · Apr 27, 2005 · Neurology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/JXL/K050188 ## Device Facts - **Applicant:** Episafe Medical Devices, Ltd. - **Product Code:** [JXL](/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/JXL.md) - **Decision Date:** Apr 27, 2005 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 882.5070 - **Device Class:** Class 2 - **Review Panel:** Neurology - **Attributes:** Therapeutic, Pediatric ## Indications for Use The EpiGuard is intended for the prevention of oral soft tissue damage during epileptic tonic-clonic seizures proceeded by an aura. ## Device Story EpiGuard is a single-use, biocompatible silicone oral protective device; functions as a physical barrier to prevent tongue and cheek damage during epileptic tonic-clonic seizures. Device maintains open airway; allows free flow of air and vomit. Design features include grip under palatals and teeth; held in front by interior surface of lips to prevent swallowing. Dimensions based on dental impressions of men and women over age 10. Device is provided clean (non-sterile). ## Clinical Evidence Observational study conducted on 10 subjects using 3 devices (30 total trials). Subjects graded 13 performance aspects on a 1-5 scale. Results indicated no objectionable performance. ## Technological Characteristics Biocompatible silicone construction; single-use; non-sterile. Dimensions based on dental impressions of individuals >10 years old. Mechanical bite block design; no energy source or software components. ## Regulatory Identification A bite block is a device inserted into a patient's mouth to protect the tongue and teeth while the patient is having convulsions. ## Predicate Devices - Ventil-A Bite Block ([K992269](/device/K992269.md)) - MouthGuard Bite Block ([K864181](/device/K864181.md)) - Sage Bite Block (Pre-Amendment) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ ।। ## KOSO 188 510(k) Summary Pursuant to CFR 807.92, the following 510(k) Summary is provided: | 1. (a) Submitter Address: | MedicSense, Ltd.
Galdani Bldg
58b Amal St.
Kiriat Arie, Petach Tikya, Israel
www.medicsense.com | |-----------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 1. (b) Manufacturer Address: | EpiSafe Medical Devices, Ltd.
84 Yitzhak Rabin Rd.
Givataym, Israel 53483
972-3-571-0768 | | Mfg. Phone: | Eran Lavi, CEO | | Contact Person: | | | Date: | January 19, 2005 | | 2. Device & Classification Name: | Bite Block, Class 2, Product Code 84JXL, 21 CFR 882.5070
EpiGuard | | 3. Predicate Devices: | Ventil-A Bite Block K992269
MouthGuard Bite Block K864181
Sage Bite Block Pre-Amendment | | 4. Description: | The EpiGuard is a single use oral protective device manufactured from
biocompatible silicone. It is provided clean (non-sterile). Besides providing a
physical barrier to prevent tongue and cheek damage of the user, the device
will maintain an open airway in the mouth cavity and allow the free flow of air
and vomit. In addition, the device is griped under the palatals and teeth of
the user while also being held in front by the interior surface of the lips. This
allows the EpiGuard to be fixed to the necessary position to prevent it from
being swallowed. | | 5. Intended Use: | The EpiGuard is intended for the prevention of oral soft tissue damage
during epileptic tonic-clonic seizures proceeded by an aura. | | 6. (a) Comparison of Technological Characteristics: | With respect to technology, the EpiGuard is substantially equivalent to its
predicate devices of being a bite block in terms of design principles. Its
dimensions were based upon the measurements from dental impressions of
men and women above the age of 10. The biocompatible material has the
necessary tensile strength properties to prevent degradation when utilized. | | 6. (b) Clinical Testing: | An observational study was conducted on 10 subjects with 3 devices (30
trials total) to evaluate 13 specific aspects of the EpiGuard. The subjects
graded the performance of the device on a scale of 1-5. The outcome of this
study did not indicate any objectionable performance of the device | {1}------------------------------------------------ DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/1/Picture/2 description: The image shows the seal of the Department of Health & Human Services (HHS). The seal features a stylized eagle with three stripes forming its body, symbolizing health, hope, and service. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle. APR 2 7 2005 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 EpiSafe Medical Devices, LTD. C/o Mr. George J. Hattub, RAC & CQE Senior Staff Consultant MedicSense, Ltd. 291 Hillside Avenue Somerset, Massachusetts 02726 Re: K050188 Trade/Device Name: EpiGuard Regulation Number: 21 CFR 882.5070 Regulation Name: Bite block Regulatory Class: II Product Code: JXL Dated: April 13, 2005 Received: April 15, 2005 Dear Mr. Hattub: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {2}------------------------------------------------ Page 2 – Mr. George J. Hattub This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115 . Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Minos O. Perez Miriam C. Provost, Ph.D. Acting Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ ## Indications for Use 510(k) Number (if known): Device Name: EpiGuard Indications For Use: The EpiGuard is intended for the prevention of oral soft tissue damage during epileptic tonic-clonic seizures proceeded by an aura. Prescription Use X AND/OR (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Eun Citta Page 1 of 1 --- **Source:** [https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/JXL/K050188](https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/JXL/K050188) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com